Matt Abernethy Insider Trades & Stock Holdings

Fate Therapeutics, Inc. · Latest filing Jun 12, 2026

Matt Abernethy at Fate Therapeutics, Inc. has 1 Form 4 trade on file since Jun 12, 2026. Latest filing: acquired 87.90K shares of $FATE on Jun 12, 2026.

Trades on file

1

Open-market bought

$0

Open-market sold

$0

Net open-market

$0

Latest filing

Jun 12, 2026

All insider trades by Matt Abernethy

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Jun 12, 2026	$FATE	Buy (Grant or award)	87.90K	$0	—			+4.4%	+46.6%				—

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks Matt Abernethy traded

• $FATE

Frequently asked questions

What was Matt Abernethy's latest insider trade?

acquired 87.90K shares of $FATE on Jun 12, 2026.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.